Works in Cancer Chemotherapy & Pharmacology, 2016, Vol 78, Issue 3


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study).

    Published in:
    2016
    By:
    • Takahashi, Takao;
    • Emi, Yasunori;
    • Oki, Eiji;
    • Kobayashi, Kazuma;
    • Tsuji, Akihito;
    • Shimokawa, Mototsugu;
    • Tanaka, Takaho;
    • Akagi, Yoshito;
    • Ogata, Yutaka;
    • Baba, Hideo;
    • Yoshida, Kazuhiro;
    • Natsugoe, Shoji;
    • Maehara, Yoshihiko;
    • Kyushu Study Group of Clinical Cancer (KSCC)
    Publication type:
    journal article
    13

    A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab.

    Published in:
    2016
    By:
    • Takahashi, Naoki;
    • Iwasa, Satoru;
    • Fukahori, Masaru;
    • Sudo, Kazuki;
    • Sasaki, Yusuke;
    • Shoji, Hirokazu;
    • Honma, Yoshitaka;
    • Okita, Natsuko;
    • Takashima, Atsuo;
    • Hamaguchi, Tetsuya;
    • Boku, Narikazu;
    • Shimada, Yasuhiro;
    • Honda, Kazufumi;
    • Yamada, Tesshi;
    • Yamada, Yasuhide;
    • Okita, Natsuko Tsuda
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20
    21

    Editorial.

    Published in:
    2016
    Publication type:
    journal article
    22

    Editorial.

    Published in:
    2016
    Publication type:
    Historical Material
    23